Table 2 Protein content obtained from BALF after whole lung lavage, and quasi-static compliance and elastance as measured by FlexiVent.

From: The Antibacterial and Anti-inflammatory Activity of Chicken Cathelicidin-2 combined with Exogenous Surfactant for the Treatment of Cystic Fibrosis-Associated Pathogens

Treatment

Protein Content (mg/kg BW)

Quasi-Static Compliance (ml/cmH2O)

Quasi-Static Elastance (cmH2O/ml)

Control

21.60 ± 3.0

0.0777 ± 0.016

13.278 ± 2.70

P. aeruginosa

 Heat-killed

20.56 ± 9.7

0.0718 ± 0.0080

14.077 ± 1.76

 Heat+CATH-2

19.44 ± 5.9

0.0755 ± 0.0069

13.347 ± 1.34

 Heat+(BLES+CATH-2)

17.58 ± 4.9

0.0801 ± 0.0064

12.558 ± 1.07

S. aureus

 Heat-killed

20.79 ± 5.2

0.0754 ± 0.0132

13.700 ± 3.02

 Heat+CATH-2

20.98 ± 7.8

0.0736 ± 0.0080

13.742 ± 1.64

 Heat+(BLES+CATH-2)

18.39 ± 8.0

0.0712 ± 0.0071

14.156 ± 1.46